Notably, mutations in NLRP3 (first discovered as cryopyrin) are responsible for a group of disorders known as cryopyrin-associated autoinflammatory syndromes (CAPS) [19]. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.